Wei et al. showed that intraperitoneal injections of CAPE (40 mg/kg/day) protected hypoxic ischemia-induced neonatal rat brain damage by inhibiting caspase-3 activation, expression of inducible nitric oxide synthase, and Ca2+-induced cytochrome c release [12]. This evidence concerns the gene CASP3 and ischemia.